Evidence map›Paper›PMID 29434452›Full record

ArticleWorld journal of gastroenterology2018

A-Jian Li, Hua-Guang Li, Er-Jiang Tang, Wei Wu, Ying Chen, Hui-Hong Jiang, Mou-Bin Lin, Lu Yin

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Association ofGenetics research · 2022
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Rs11479 inPharmacogenomics and personalized medicine · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. MicroRNA Assisted Gene Regulation in Colorectal Cancer.International journal of molecular sciences · 2019
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

A-Jian LiDepartment of General Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Hua-Guang LiCenter for Translational Medicine, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, China.
Er-Jiang TangCenter for Translational Medicine, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, China.
Wei WuDepartment of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, China.
Ying ChenCenter for Translational Medicine, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, China.
Hui-Hong JiangDepartment of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, China.
Mou-Bin LinDepartment of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, China.
Lu YinDepartment of General Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China. yindalu@tongji.edu.cn.
Tongji University · CNShanghai Municipal People's Government · CNShanghai Tenth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the predictive value of

methodsIn this study, a total of 315 patients with histologically proven CRC were enrolled from Yangpu Hospital affiliated to Shanghai Tongji University between 2007 and 2011. Of these patients, 241 with stage II/III CRC received 5-fluorouracil-based adjuvant chemotherapy. Formalin-fixed paraffin-embedded lesion samples of the patients with curatively resected CRC were collected. Next-generation sequencing was performed to identify somatic gene mutations. The correlation of

resultsAmong the 241 patients with stage II/III in this cohort, the

conclusionDouble mutation of

Indexed as

AgedAntimetabolites, AntineoplasticBiomarkers, TumorChemotherapy, AdjuvantChinaClass I Phosphatidylinositol 3-KinasesColectomyColorectal NeoplasmsFemaleFluorouracilHumansKaplan-Meier EstimateMaleMiddle AgedMutationNeoplasm StagingAntimetabolites, AntineoplasticBiomarkers, TumorClass I Phosphatidylinositol 3-KinasesFluorouracilPIK3CA protein, humanTP53 protein, humanTumor Suppressor Protein p535-fluorouracilColorectal cancerDouble mutationOverall survivalPIK3CATP53

Identifiers

PMID29434452
PMCPMC5799864
OpenAlexW2787828861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.